Close Menu

NEW YORK (360Dx) – Researchers at Indiana University School of Medicine, the Indianapolis VA Medical Center, and the Scripps Research Institute are developing gene expression-based biomarkers for a blood-based diagnostic test to measure and quantify pain.

The test could have a positive impact on the opioid epidemic, the researchers said, leading to more precise and alternative treatments for patients experiencing pain.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.